UK's GenInCode partners with Family Heart Foundation and UT Southwestern to implement LIPID inCode test for early detection and treatment of familial hypercholesterolemia in US healthcare settings.

GENinCode Plc, a UK genetics firm, has partnered with the Family Heart Foundation and UT Southwestern to implement the LIPID inCode test for diagnosing familial hypercholesterolemia (FH) in US healthcare settings. Funded by a Department of Defense grant, the initiative aims to enhance early detection and treatment of FH, a hereditary condition linked to high cholesterol and increased cardiovascular disease risk. The collaboration also emphasizes family screening to identify at-risk individuals.

September 20, 2024
5 Articles